Qing Wan

State Key Laboratory Of Cardiovascular Disease, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Correction to: Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.

Correction to: Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.

Journal: Circulation research

Published: February 26, 2026

Novel Mouse Model of Coronary Atherosclerosis With Myocardial Infarction: Insights Into Human CAD.

Novel Mouse Model of Coronary Atherosclerosis With Myocardial Infarction: Insights Into Human CAD.

Journal: Circulation research

Published: June 09, 2025

Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation.

Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: November 26, 2024

Arachidonic acid synergizes with aspirin preventing myocardial ischaemia-reperfusion injury and mitigates bleeding risk.

Arachidonic acid synergizes with aspirin preventing myocardial ischaemia-reperfusion injury and mitigates bleeding risk.

Journal: Cardiovascular research

Published: March 26, 2024

Complement factor B, not the membrane attack complex component C9, promotes neointima formation after arterial wire injury.

Complement factor B, not the membrane attack complex component C9, promotes neointima formation after arterial wire injury.

Journal: Atherosclerosis

Published: February 09, 2024

Factor XII and prekallikrein promote microvascular inflammation and psoriasis in mice.

Factor XII and prekallikrein promote microvascular inflammation and psoriasis in mice.

Journal: British journal of pharmacology

Published: July 17, 2023

Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.

Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.

Journal: Circulation research

Published: July 28, 2022

Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell Dynamics.

Stage-Dependent Impact of RIPK1 Inhibition on Atherogenesis: Dual Effects on Inflammation and Foam Cell Dynamics.

Journal: Frontiers in cardiovascular medicine

Published: May 26, 2021

Drug Discovery for Coronary Artery Disease.

Drug Discovery for Coronary Artery Disease.

Journal: Advances in experimental medicine and biology

Published: April 05, 2020

The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury.

The cyclooxygenase-1/mPGES-1/endothelial prostaglandin EP4 receptor pathway constrains myocardial ischemia-reperfusion injury.

Journal: Nature communications

Published: May 20, 2018

Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE2 (Prostaglandin E2) and the Endothelial EP4 (Prostaglandin E Receptor) in Vascular Responses to Injury.

Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE2 (Prostaglandin E2) and the Endothelial EP4 (Prostaglandin E Receptor) in Vascular Responses to Injury.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: December 08, 2017

2D MoS2 Neuromorphic Devices for Brain-Like Computational Systems.

2D MoS2 Neuromorphic Devices for Brain-Like Computational Systems.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: March 22, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026